ANALYSIS OF COMPLICATIONS IN PATIENTS TREATED WITH ABDOMINOPELVIC RADIATION-THERAPY FOR OVARIAN-CARCINOMA

被引:56
作者
FYLES, AW
DEMBO, AJ
BUSH, RS
LEVIN, W
MANCHUL, LA
PRINGLE, JF
RAWLINGS, GA
STURGEON, JFG
THOMAS, GM
SIMM, J
机构
[1] PRINCESS MARGARET HOSP, DEPT MED, TORONTO M4X 1K9, ONTARIO, CANADA
[2] PRINCESS MARGARET HOSP, DEPT BIOSTAT, TORONTO M4X 1K9, ONTARIO, CANADA
[3] TORONTO BAYVIEW REG CANC CTR, DIV RADIAT ONCOL, TORONTO, ONTARIO, CANADA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1992年 / 22卷 / 05期
关键词
OVARIAN CANCER; RADIATION THERAPY; COMPLICATIONS;
D O I
10.1016/0360-3016(92)90778-G
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between 1971 and 1985, 598 patients with ovarian carcinoma were treated with abdomino-pelvic radiation therapy. Acute complications included nausea and vomiting in 364 patients (61%) which were severe in 36, and diarrhea in 407 patients (68%), severe in 35. Leukopenia (< 2.0 x 10(9) cells/liter) and thrombocytopenia (< 100 x 10(9) cells/liter) occurred in 64 patients (11%) each. Treatment interruptions occurred in 136 patients (23%), and 62 patients (10%) did not complete treatment. In both situations the most common cause was myelosuppression. Late complications included chronic diarrhea in 85 patients (14%), transient hepatic enzyme elevation in 224 (44%), and symptomatic basal pneumonitis in 23 (4%). Serious late bowel complications were infrequent: 25 patients (4.2%) developed bowel obstruction and 16 required operation. Multivariate analysis was unable to determine any significant prognostic factors for bowel obstruction; however, the moving-strip technique of radiation therapy was associated with a significantly greater risk of developing chronic diarrhea, pneumonitis, and hepatic enzyme elevation than was the open beam technique. We conclude that abdomino-pelvic radiation therapy as used in these patients is associated with modest acute complications and a low risk of serious late toxicity.
引用
收藏
页码:847 / 851
页数:5
相关论文
共 18 条
[11]   EARLY STAGE OVARIAN-CANCER - A RANDOMIZED CLINICAL-TRIAL COMPARING WHOLE ABDOMINAL RADIOTHERAPY, MELPHALAN, AND INTRAPERITONEAL CHROMIC PHOSPHATE - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-REPORT [J].
KLAASSEN, D ;
SHELLEY, W ;
STARREVELD, A ;
KIRK, M ;
BOYES, D ;
GERULATH, A ;
LEVITT, M ;
FRASER, R ;
CARMICHAEL, J ;
METHOT, Y ;
WILLAN, A .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1254-1263
[12]   OUTCOME OF PATIENTS WITH UNFAVORABLE OPTIMALLY CYTOREDUCED OVARIAN-CANCER TREATED WITH CHEMOTHERAPY AND WHOLE ABDOMINAL RADIATION [J].
LEDERMANN, JA ;
DEMBO, AJ ;
STURGEON, JFG ;
FINE, S ;
BUSH, RS ;
FYLES, AW ;
PRINGLE, JF ;
RAWLINGS, GA ;
THOMAS, GM ;
SIMM, J .
GYNECOLOGIC ONCOLOGY, 1991, 41 (01) :30-35
[13]   POSTOPERATIVE RADIATION-THERAPY FOR EPITHELIAL OVARIAN-CANCER - THE CURATIVE ROLE BASED ON A 24-YEAR EXPERIENCE [J].
MARTINEZ, A ;
SCHRAY, MF ;
HOWES, AE ;
BAGSHAW, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (07) :901-911
[14]   TOXICITY OF OPEN-FIELD WHOLE ABDOMINAL IRRADIATION AS PRIMARY POSTOPERATIVE TREATMENT IN GYNECOLOGIC MALIGNANCY [J].
SCHRAY, MF ;
MARTINEZ, A ;
HOWES, AE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (02) :397-403
[15]   RANDOMIZED STUDY OF WHOLE-ABDOMEN IRRADIATION VERSUS PELVIC IRRADIATION PLUS CYCLOPHOSPHAMIDE IN TREATMENT OF EARLY OVARIAN-CANCER [J].
SELL, A ;
BERTELSEN, K ;
ANDERSEN, JE ;
STROYER, I ;
PANDURO, J .
GYNECOLOGIC ONCOLOGY, 1990, 37 (03) :367-373
[16]   TOTAL ABDOMINAL IRRADIATION IN STAGE-I AND STAGE-II CARCINOMA OF THE OVARY [J].
VANBUNNINGEN, B ;
BOUMA, J ;
KOOIJMAN, C ;
WARLAMRODENHUIS, CC ;
HEINTZ, APM ;
VANLINDERT, A .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (04) :305-310
[17]   DETERMINANTS OF SURVIVAL OF PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA FOLLOWING WHOLE ABDOMEN IRRADIATION (WAR) [J].
WEISER, EB ;
BURKE, TW ;
HELLER, PB ;
WOODWARD, J ;
HOSKINS, WJ ;
PARK, RC .
GYNECOLOGIC ONCOLOGY, 1988, 30 (02) :201-208
[18]  
WHELAN TJ, IN PRESS INT J RAD O